© 2026 Sinochem Nanjing Corporation,
All Right Reserved
The story of Ipriflavone and 7-Methoxyisoflavone began in the late twentieth century, a time when the world’s population started living longer and bone health took center stage in discussions about aging. Researchers first turned their attention to these flavone derivatives because osteoporosis had become a looming public health issue. Traditional medicine used isoflavones from foods like soy for years, but synthetic analogs promised more predictable effects. Japanese scientists synthesized Ipriflavone in the 1960s, hoping to harness and boost some of these natural benefits. This sparked a race to explore similar compounds, which eventually led to the discovery of 7-Methoxyisoflavone. By the 1980s, research ramped up in Europe and Asia, paving the way for these molecules to move from the lab to the pharmacy shelf.
Ipriflavone stands out for its chalky, white crystalline powder form, commonly marketed for its potential support of bone metabolism. 7-Methoxyisoflavone shares a similar backbone yet has slightly altered chemical features, which changes its appeal for different users. Both compounds appear in supplements pitched toward older adults hoping to sidestep the challenges of bone thinning. Companies promote these products for anyone facing risk factors, like postmenopausal women or individuals receiving long-term corticosteroid therapy. The promise of supporting bone strength, while still hotly debated in clinical circles, draws continuing attention from supplement manufacturers and researchers alike.
Pure Ipriflavone turns up as an odorless, tasteless powder, non-hygroscopic, and melts at about 172°C. Its molecular formula, C18H16O3, puts it squarely in the group of synthetic isoflavones. It dissolves poorly in water but mixes better with organic solvents like ethanol or DMSO, which guide its formulation in capsules and tablets. 7-Methoxyisoflavone, or C16H12O4, looks similar but with a methoxy group at the 7-position, changing how it interacts with other molecules and the body. These small shifts in chemical structure influence daily use, from ease of production to long-term stability on the shelf, and govern how manufacturers store, blend, and pack these materials into consistent dosages.
Tight rules outline what legitimate Ipriflavone or 7-Methoxyisoflavone should look and feel like. High-purity grades come with over 98% active compound and must show only trace amounts of heavy metals and other impurities. Labels for food supplements need to list these percentages, plus serving size and any co-ingredients, as required by authorities in the EU, USA, China, and beyond. Manufacturers supply certificates of analysis with every batch, answering to buyers who demand proof of content and safety. I’ve checked labels that included not just purity, but also details on allergens, shelf life, and storage temperature, reflecting a world where consumers expect to know everything up front.
The journey from raw materials to finished product winds through multiple chemical steps. Ipriflavone starts with simple phenolic compounds, undergoing etherification and acylation—basic tools for organic synthesis. Factories need to keep reactions under precise temperatures and pH, which isn’t always easy on a commercial scale. 7-Methoxyisoflavone presents its own synthetic hurdle: introducing the methoxy group at the exact right location, avoiding side products that muddy purity. Some labs use green chemistry shortcuts, aiming to reduce waste or hazardous by-products. The scale-up of these synthetic routes, moving from beaker to factory batch, challenged chemists to develop efficient purification strategies, usually crystallization and chromatography.
Both molecules allow for derivatives, but not without risk of spoilage or unplanned reactions. Hydrolysis, for example, can break down Ipriflavone if exposed to the wrong conditions during manufacture or storage. Some researchers experiment with ester or ether formation, tweaking the basic molecule for improved absorption. Derivatization isn’t just academic—it hopes to find tweaks that give better outcomes in humans. Building on this tradition, newer labs look to conjugate isoflavones with nanoparticles or lipophilic groups, trying to open new avenues for delivery and use.
Marketing departments go wild with alternate names. Ipriflavone appears as "Ostac", "Yambolap", or just "7-isopropoxyisoflavone" on some supplements. 7-Methoxyisoflavone pops up as "Methoxyflavone" or "Methyl Isoflavone." Sometimes, especially online, these names confuse shoppers looking for clinical studies or regulatory updates. Accurate labeling matters—missteps here invite enforcement by regulators or mistrust among users.
Following the rules is not optional. Ipriflavone once saw broad use, but safety concerns like its effects on white blood cells and liver led authorities to rethink its free sale as a supplement in some countries. Manufacturing plants implement Good Manufacturing Practices (GMP), set up environmental controls, and use occupational exposure limits to protect workers from dust or accidental contact. Suppliers in North America, Europe, and Asia know one contamination scandal can tank months of hard work. Industry lab tests, ranging from identity checks to microbial screenings and even genetic toxicology panels, help build buyer trust. Traceability, where every batch can be tracked from start to finish, is now the standard. Too many companies learned this lesson the hard way.
Bones set the stage, but these compounds wander further afield. Nutraceutical blends often feature Ipriflavone, occasionally paired with ingredients like calcium, Vitamin D, or magnesium, forming the backbone of many “bone strength” complexes. Athletes once grabbed bottles of 7-Methoxyisoflavone, chased by claims about muscle-building or improved training recovery—despite a lack of ironclad research. Medical professionals watched these trends closely, wary of exaggerated claims and subtle risks for long-term users. Safe or not, interest in these compounds as ingredients for tailored health solutions still draws in product developers and researchers.
Clinical research marks both promise and challenge. Ipriflavone showed early sparks in animal and laboratory tests, where it slowed bone loss and prompted new bone formation. Yet human trials failed to deliver consistent results, and regulatory authorities cooled on its use, requesting more data on rare but serious side effects. 7-Methoxyisoflavone offers even fewer high-quality studies. Academic groups try to untangle the molecular pathways at work, sometimes pointing to weak estrogenic effects or antioxidant benefits. Much-needed research dives into pharmacokinetics and interactions with other medicines, but private investment lags due to losses after early market hype faded. That said, a handful of players chase improved delivery systems, including nanoparticles and prodrugs, hoping to generate the excitement seen during the early supplement boom.
Red flags flashed in the late 1990s. Reports trickled in of Ipriflavone lowering white blood cell counts, raising infection risk for a small slice of users. Regulatory bodies in the EU and Japan responded with restrictions, and doctors paused to review safety warnings. Unpublished cases linked high doses to possible liver enzyme changes, sending more researchers back to animal studies to review long-term safety. 7-Methoxyisoflavone, in comparison, lacks a deep catalog of toxicity findings, largely because widespread use never reached the heights of its sibling. Without robust, independent research, caution prevails among the few practitioners who still consider these supplements for certain clients or trial protocols.
Eyes stay fixated on healthy aging—the sector unlikely to shrink as populations gray worldwide. Some see a future for Ipriflavone and related molecules in combination therapies, tweaking their chemical backbones for targeted uses, possibly in slow-release formulations or with other micronutrients. Researchers and startups eye the latest trends, like using AI to screen for improved analogs or nanotechnology to boost absorption rates. Any real revival hinges on transparent reporting, strict oversight, and realistic claims. If the industry leans into these demands, avoids the old traps of overstatement and poor quality control, both Ipriflavone and 7-Methoxyisoflavone could find renewed relevance for people looking to guard their health deep into old age.
Ipriflavone often comes up in conversations about bone health. This synthetic derivative of naturally occurring isoflavones once drew a fair bit of attention for its promise in supporting bones, especially in postmenopausal women. Studies have suggested that Ipriflavone helps slow down bone breakdown and supports the work of cells that build new bone. That made it an interesting supplement for people dealing with weakening bones or those at risk of osteoporosis.
Not all outcomes have matched the early hype. Researchers conducted trials involving women past menopause, the group at highest risk for osteoporosis. Results showed Ipriflavone did not always prevent bone loss or reduce the chances of bone fractures. Some scientists still keep an eye on it for possible future applications, but for now, established treatments like bisphosphonates or hormone therapy hold stronger track records.
One thing about Ipriflavone that sticks with people is its safety profile. Most users report tolerating it well. Researchers in Italy published in the Journal of Bone and Mineral Research that minor stomach discomfort was the most common problem, with rare liver changes in blood tests that usually resolved. For people who worry about tolerating prescription drugs, that mattered.
Athletes and fitness enthusiasts sometimes talk about 7-Methoxyisoflavone. Not to be confused with anabolic steroids, it belongs to the family of plant-based flavones. These compounds often catch attention for possible support in muscle growth and body composition. Supplement sellers claim 7-Methoxyisoflavone can help the body build lean muscle faster, shed unwanted fat, and speed up recovery after hard workouts.
Large-scale studies have not proven these muscle-building claims. Research remains thin. The U.S. Food and Drug Administration does not recognize 7-Methoxyisoflavone as a medicine or approve it for any health claim. Still, you see gym-goers put faith in it, hoping for any edge. Here’s where some caution pays off. Without long-term human studies, no one knows all the side effects or interactions.
My own background in sports nutrition has shown me that fads like this usually cycle through gyms quickly. If something sounds too good to be true, it usually disappears from supplement shelves the next time regulations tighten up.
Supplements like Ipriflavone and 7-Methoxyisoflavone invite a real temptation: the shortcut. Everyone wants solid bones or a stronger body. Solid evidence and regulatory approval often trail behind the marketing claims. A safe bet is to pay attention to reports from trustworthy scientific bodies, such as the National Institutes of Health. Talk honestly with doctors and nutritionists, especially when there’s a health risk involved, such as osteoporosis or muscle loss from medical issues.
For bone support, calcium, vitamin D, resistance exercises, and sometimes established medications can do plenty of heavy lifting. For muscle growth, protein, balanced nutrition, and steady training matter more than any isolated plant compound. Supplements may fill some gaps, but they rarely replace the basics of health. As researchers keep studying these substances, staying grounded in proven habits protects both health and wallet.
Plenty of people exploring supplements stumble across ipriflavone and its cousin, 7-methoxyisoflavone, especially those who care about bone health or muscle growth. Both fall into the group called isoflavones, which come from plants and draw interest for their potential effects on bones and muscles. Their popularity grew after early studies suggested ipriflavone could help women maintain bone density, especially after menopause. Some athletes and bodybuilders started using these for muscle support, hoping for an edge without risky hormones.
Some research suggests ipriflavone can slow down bone loss in women, particularly during their postmenopausal years. People working in healthcare often point out a large study from the early 2000s, which looked at whether ipriflavone really protects bones. In that study, ipriflavone didn’t stop bone loss as much as many hoped, and some participants dropped out due to side effects. That’s a red flag for anyone thinking this is a silver bullet.
More concern came when the same study found that some people who took high doses developed low white blood cell counts. This left them open to infections. That’s not a small thing to brush off. On the other hand, most people didn’t experience this drop. The trouble is, scientists still don’t know why it happens in some and not in others.
Doctors and researchers have raised eyebrows over long-term safety. Ipriflavone and 7-methoxyisoflavone haven’t undergone the same years of harsh testing as prescription medications. Most studies ran for only six months to a year. Nobody can say with confidence what happens after years of steady use. People taking blood thinners or certain heart medications face higher risks, too, because these supplements can interfere with how those drugs work.
Older adults, women with frail bones, and anyone with a weak immune system need to think things through before trying these supplements. Young athletes sometimes look to 7-methoxyisoflavone hoping for lean muscle growth, but the research there is thin. Online forums and sellers often hype up the benefits a lot more than the facts support. As with any supplement, purity can also be an issue—sometimes pills contain more or less than the label claims, or include unwanted byproducts.
I’ve seen plenty of folks at the pharmacy counter asking about the next best thing for bones or strength. In these situations, honest conversations matter. Doctors and pharmacists can check for risky drug interactions and suggest regular blood count monitoring if someone insists on trying ipriflavone. People with weak immune systems or who take immune-suppressing medicine probably should skip these supplements altogether. For those looking to protect their bones, focusing on calcium, vitamin D, regular exercise, and proven medical therapies makes more sense. When someone’s looking for muscle gains, prioritizing balanced diets, safe training, and rest brings better rewards.
Any time a headline or ad promises big gains from a supplement, a little skepticism pays off. Real evidence, advice from trusted healthcare providers, and personal health history always deserve more weight than testimonials or hype. The safest approach: ask questions, demand proof, and avoid treating untested supplements as miracle cures.
Ipriflavone supplements show up in plenty of online searches about bone health, often pitched to those worried about osteoporosis. In Japan and some parts of Europe, doctors have prescribed it since the 1980s for women facing osteoporosis risk after menopause. Advertisements frequently paint it as a natural bone protector. Still, my time working alongside pharmacists has shown that rarely does any pill act with only benefits.
Reports document side effects that stack up when people take larger doses of Ipriflavone long-term. For some, digestive complaints show up—nausea, stomach pain, diarrhea. Blood counts also take a hit in a minority of people. White blood cell counts, especially neutrophils, drop enough to push some users into dangerous territory, increasing infection risk. In one stretch of clinical trials, about 13% of patients taking Ipriflavone saw decreases serious enough to stop treatment and receive medical attention.
Allergic symptoms pop up as well, with rashes and itching, sometimes serious enough to land people in the ER. Dizziness, dry mouth, and headaches have been mentioned, too, but these remain less common. Liver health comes into focus if high doses are used for months at a stretch. Livers handle drug breakdown, and some case reports add Ipriflavone to the list of things that might nudge routine liver tests upward or even spark liver injury in the most sensitive people. If an older adult takes other medications processed through the liver, or drinks alcohol regularly, combining these risks can bring more trouble.
7-Methoxyisoflavone hit the market pushed by bodybuilding forums, marketed as an anabolic that skips the hormone risk. Claims hinge on studies in test tubes, not large clinical trials in humans. Most side effect reports come from people chasing muscle gains, some buying products with uncertain dosing and purity.
Reports from bodybuilders reflect experiences with digestive upset—bloating and stomach pain stand out. Headaches and mild dizziness show up next. Some forum users describe feeling jittery, agitated, or battling minor sleep problems. Lab studies raise questions about effects on liver enzyme systems, almost like 7-Methoxyisoflavone tries to pick a fight with the same detox machinery as Ipriflavone.
Real safety data lags far behind marketing claims. The FDA hasn’t cleared either substance for any disease, so buying them as supplements means accepting unpredictability. No major studies follow users of 7-Methoxyisoflavone for months or years, so nobody can say with confidence what rare or serious risks may show up. If people already handle medical conditions impacting digestion, the immune system, or the liver, caution makes sense.
Some turn to supplements like Ipriflavone and 7-Methoxyisoflavone in hopes of skipping prescription drugs and harsh side effects. Yet known risks deserve a hard look before swallowing any capsule. Checking with a doctor or pharmacist saves some grief, especially if pre-existing medical problems or regular medications make interactions more likely. Blood pressure, immune status, and ongoing prescription lists matter here.
Long-term safety can’t be guessed from short trials or animal experiments alone. In my experience advising friends or patients, I remind them that real-world reactions sometimes sneak up months later, well after marketing promises fade. Anyone taking these substances should pay attention to symptoms, schedule check-ins for blood work, and stay skeptical of miracle claims passed around in online forums. Nothing beats asking for up-to-date health advice, directly from those trained to guide tough choices in medicine.
Walking through supplement shelves, it's easy to feel swamped by new compounds, each with bold claims. Ipriflavone and 7-Methoxyisoflavone have gained a fair amount of attention, especially in the fitness and wellness community. These aren't your usual vitamins or minerals — they belong to a group called flavonoids. Most folks want to know how to take these two, hoping to strengthen bones or support muscle goals.
Ipriflavone has roots in the management of bone health. Many adults, especially women past menopause, struggle to keep their bones sturdy as they age. Researchers found some early evidence that this compound could help slow down bone loss, likely by how it interacts with the cells in bone tissue. A common dose from most studies sits around 600 mg per day, often split across two or three meals. I recommend taking it with food, since many folks complain of stomach aches if swallowed on an empty stomach.
Folks taking blood thinners or with certain stomach issues might run into unwanted effects like digestive upset or interactions with other medications. This is why a doctor’s advice isn’t just a formality — skipping that chat sometimes leads to more harm than good.
This one pops up mostly in bodybuilding and aging discussions. The talk comes from studies showing possible support for lean muscle retention without the side effects of anabolic steroids. You'll often find 100 to 200 mg on supplement bottles, split twice per day. Absorption seems better when taken with a meal that contains healthy fats, so pairing it with morning eggs or an avocado snack isn't a bad idea.
I never skip checking for possible allergies with any new supplement, especially anything related to soy or legumes, since many flavonoids come from those sources. Many claims float around, but long-term safety still isn’t rock-solid. Clinical trials run short, so the best move is sticking within doses suggested on reputable labels.
There’s a reason reputable sources, like the National Institutes of Health, still urge caution. Not everyone responds the same way, and supplements are often less regulated than medicines from the pharmacy. Sometimes, I've seen unexpected headaches or odd muscle cramps in people who don’t typically react. Some drugs like anti-coagulants, steroids, or even certain antibiotics can have conflicts with both compounds, so a direct chat with a healthcare provider who knows your medical history can’t be overlooked.
A lot of folks hope that supplements like ipriflavone and 7-methoxyisoflavone can skip them ahead in fitness routines or keep bones hearty into older age. The truth is that nothing beats balance — keeping a varied diet, staying active, and checking in with a medical professional go a long way. Supplements only fill small gaps, not whole craters in health. For anyone new to these compounds, start low, track how you feel, and pause straight away if anything seems off. Carefully read labels, check for third-party testing, and always keep your doctor in the loop.
Health stores and supplement shelves often promote ipriflavone and 7-methoxyisoflavone for bone strength and muscle support. Both belong to a class known as isoflavones, which are plant-derived compounds sometimes used in efforts to support aging bones and improve athletic performance. They sound natural and safe, but people often forget that “natural” does not mean free from possible problems—especially when it comes to how they might act alongside other drugs.
My time spent behind the pharmacy counter has taught me one thing: people ask more about prescription side effects than they do about supplement interactions. Yet, most drugs are handled by a few main liver enzymes, and the challenge grows once supplements get into that mix. Isoflavones don’t just quietly slip through—they can hog enzymes, nudge other drugs to work faster or slower, or even change how much medicine stays in your bloodstream.
Ipriflavone has been studied for its effects on osteoporosis, especially in older women. In the lab, it’s been shown to either block or stimulate certain enzyme pathways that break down medicines. Notably, it can affect the enzyme CYP1A2. This enzyme also helps clear caffeine, some antidepressants, and even the blood thinner warfarin out of the body. If ipriflavone slows things down, you can end up with too much of those drugs in your system, raising the risk of dangerous side effects—like bleeding with blood thinners.
Researchers have also seen ipriflavone lower white blood cell counts in some people. This matters for anyone already taking drugs that suppress the immune system, such as steroids or certain chemotherapy products. Piling ipriflavone on top could lead to a greater chance of infections.
Sports supplements sometimes contain 7-methoxyisoflavone because of its reputation for improving muscle mass. Its metabolic fate looks a bit like other isoflavones, so the risk for interactions lingers. There isn’t a huge pile of clinical trials, but early data says it could compete for the same enzyme systems, particularly those that break down some statins, blood pressure medicines, and anxiety drugs.
It’s tough to ignore that the supplement industry doesn’t always police itself or list all risks on labels. That leaves the consumer guessing, which undermines safety. In my opinion, this gap calls for stronger oversight.
Doctors and pharmacists often do not know everything patients take—patients don’t always share, or they just forget. Every year, older adults get put in the hospital by mix-ups between over-the-counter products and prescription meds. People taking ipriflavone for bone health, for example, could be prescribed a statin, then start feeling dizzy or weak because of overlapping effects.
Better habits save lives. Keeping an up-to-date list of all supplements and prescriptions helps everyone: it leads to safer care and fewer surprises. Pharmacists check for the most common issues if they know what you’re taking. One national solution would be a rule that supplements get tested for safety with common medications—and that this info shows up right on the bottle.
In the end, the safest bet is starting every new supplement with your doctor or pharmacist in the loop. Open conversations lead to fewer hidden risks and a better shot at good health.
| Names | |
| Preferred IUPAC name | 7-Methoxy-3-phenyl-4H-1-benzopyran-4-one |
| Other names |
7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one Ipriflavon Ipriflavona Ipriflavonum 7-Isopropoxyisoflavone |
| Pronunciation | /ˌaɪ.prɪˈfleɪ.voʊn, sɛvən ˌmɛθ.ɒk.siˈaɪ.səˌfleɪ.voʊn/ |
| Identifiers | |
| CAS Number | 35212-22-7 |
| Beilstein Reference | **150723** |
| ChEBI | CHEBI:5986 |
| ChEMBL | CHEMBL1412 |
| ChemSpider | ChemSpider: 10566 |
| DrugBank | DB04573 |
| ECHA InfoCard | 03c13c8d-d47e-420d-ac17-3aca19b77eb5 |
| EC Number | EC 200-726-8 |
| Gmelin Reference | 78954 |
| KEGG | C07816 |
| MeSH | D017962 |
| PubChem CID | 65677 |
| RTECS number | YQ3150000 |
| UNII | 0K5732A8GJ |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C18H16O3 |
| Molar mass | 352.36 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.18 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 2.96 |
| Vapor pressure | 4.19E-9 mmHg at 25°C |
| Acidity (pKa) | 6.96 |
| Basicity (pKb) | 6.1 |
| Magnetic susceptibility (χ) | -80.1×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.486 |
| Dipole moment | 4.07 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Ipriflavone,7-Methoxyisoflavone: 465.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | Std enthalpy of formation (ΔfH⦵298) of Ipriflavone,7-Methoxyisoflavone: -238.4 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | −4417 kJ/mol |
| Pharmacology | |
| ATC code | M05BA02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes skin and eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02,GHS07 |
| Pictograms | 🧪⚗️💊 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P261, P264, P270, P272, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 151.8°C |
| Autoignition temperature | 400 °C (752 °F; 673 K) |
| Lethal dose or concentration | LD50 (rat, oral): >5000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Ipriflavone,7-Methoxyisoflavone: 3680 mg/kg (oral, rat) |
| NIOSH | DJ0L2D618U |
| PEL (Permissible) | Not established |
| REL (Recommended) | Recommended Exposure Limit (REL) for Ipriflavone, 7-Methoxyisoflavone: **Not established** |
| IDLH (Immediate danger) | NIOSH has not established an IDLH for Ipriflavone or 7-Methoxyisoflavone. |
